FASENRA Inj Lös 30 mg/ml Fertspr 1 ml
In stock
View at Merchant
Fasenra is a medication containing Benralizumab, a monoclonal antibody used to treat severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA) in adults by reducing eosinophil levels.
- Fasenra reduces the number of eosinophils in the blood.
- Fasenra helps prevent severe asthma attacks (exacerbations) and can improve breathing.
Specifications
- Menge
- 1 ml
Variants (1)
- 1 ml — 0.00 CHF — In stock
AI Readiness
Good foundation, but some important product data is still missing.
69%